NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding NexImmune, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 47 | 46 | −1 |
| Shares | 10.6M | 10.2M | −381.3K (−3.6%) |
| Value | $160.3M | $47.1M | −$113.3M (−70.6%) |
New holders (8)
Institutions that held NexImmune, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| M28 Capital Management LP | 133,442 | $615.0K | 0.48% |
| First Republic Investment Management, Inc. | 100,000 | $461.0K | 0.00% |
| Renaissance Technologies LLC | 50,900 | $235.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 16,778 | $77.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 15,220 | $70.0K | 0.00% |
| Two Sigma Investments, LP | 12,743 | $59.0K | 0.00% |
| UBS Group AG | 5,674 | $26.0K | 0.00% |
| High Net Worth Advisory Group LLC | 500 | $2.00K | 0.00% |
Sold out (9)
Institutions that held NexImmune, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Suvretta Capital Management, LLC | 344,223 | $5.21M |
| Raymond James & Associates | 25,957 | $393.0K |
| Victory Capital Management Inc | 11,970 | $181.0K |
| Manufacturers Life Insurance Company, The | 10,464 | $158.0K |
| MetLife Investment Management | 7,704 | $116.6K |
| SG Americas Securities, LLC | 7,524 | $114.0K |
| Metropolitan Life Insurance Co | 5,828 | $88.2K |
| US Bancorp | 131 | $2.00K |
| Signaturefd, LLC | 29 | $0 |